Your browser doesn't support javascript.
Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran.
Geraili, Ali; Badirzadeh, Alireza; Sadeghi, Maryam; Mousavi, Seyed Mahmoud; Mousavi, Parisa; Shahmoradi, Zabihollah; Hosseini, Sayed-Mohsen; Hejazi, Seyed Hossein; Rafiei-Sefiddashti, Raheleh.
  • Geraili A; Tehran, Iran Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences.
  • Badirzadeh A; Tehran, Iran Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences.
  • Sadeghi M; Tehran, Iran Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences.
  • Mousavi SM; Isfahan, Iran Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences.
  • Mousavi P; Isfahan, Iran Skin Diseases and Leishmaniasis Research Center, Department of Parasitology and Mycolog, Isfahan University of Medical Sciences.
  • Shahmoradi Z; Isfahan, Iran Skin Diseases and Leishmaniasis Research Center, Department of Parasitology and Mycolog, Isfahan University of Medical Sciences.
  • Hosseini SM; Isfahan, Iran Department of Dermatology, Al-Zahra Hospital, Isfahan University of Medical Sciences.
  • Hejazi SH; Isfahan, Iran Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences.
  • Rafiei-Sefiddashti R; Isfahan, Iran Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences.
J Parasit Dis ; 47(1): 185-191, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2260411
ABSTRACT
Toxoplasmosis has been categorized as one of the long-lasting protozoan parasitic infections. It affects almost one-third of the world's population. In recent years, several documented studies have elucidated that infected individuals have a remarkably higher incidence of distinct health problems and show various adverse effects. In the PCR-positive COVID-19 patients in Gonbad-e-Kavus, Kalaleh, and Minoodasht counties in the northern part of Iran from June 2021 to December 2021, we sought to investigate any potential relationships between the severity of COVID-19 symptoms and acute and latent toxoplasmosis caused by Toxoplasma gondii (T. gondii). Whole blood samples of 161 COVID-19 patients with positive PCR. The samples were centrifuged to separate serum and screened for two important antibodies against T. gondii (IgM and IgG) by using ELISA kits for human anti-T. gondii IgM and IgG. Anti-T. gondii IgM and IgG antibodies were detected in 8/161 (5.0%) and 42/161 (26.1%) COVID-19 patients, respectively. No significant relationships were found between Toxoplasma IgM and IgG results with clinical signs, age, sex, contact with animals, comorbidities, and also the mortality rate of people with COVID-19. These findings showed that acute and latent toxoplasmosis infections are common among patients with COVID-19; however, no significant associations were found between toxoplasma infections and the symptoms of COVID-19. Therefore, toxoplasmosis is not considered a risk factor for COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Long Covid Language: English Journal: J Parasit Dis Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Long Covid Language: English Journal: J Parasit Dis Year: 2023 Document Type: Article